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ABSTRACT 
The aim of this thesis was to further develop the microdialysis technique for studies of 
glucose metabolism and insulin resistance in human skeletal muscle in vivo and to use 
this technique to explore the effect of exercise on muscle glucose metabolism and 
insulin action. The first two studies were conducted to explore the possibility of using a 
perfusion flow rate low enough to obtain complete equilibrium between the interstitial 
and perfusion fluids and if the colloid included in the perfusion fluid for this purpose 
affected the metabolite concentrations in the dialysate. The following three studies 
focus on glucose metabolism and insulin resistance by examining the extent to which 
insulin and/or the insulin-mimetic trace element vanadate added to the perfusion fluid 
exerted local effects on the glucose metabolism in healthy and in insulin-resistant 
human skeletal muscle, at rest and following a single bout of exercise.  
It was found that to obtain complete equilibration between the perfusion fluid and the 
interstitial fluid in human skeletal muscle, a perfusion flow rate as low as 0.16 µl/min is 
necessary with the presently used catheters (Study I).  
At these low perfusion flow rates a colloid needs to be included in the perfusion fluid in 
order to keep the fluid balance and in this thesis it was shown that the colloid dextran-
70 does not affect the metabolite concentrations in the collected dialysates (Study II). 
A high cut-off microdialysis membrane can be used to infuse insulin into human 
skeletal muscle and to record its effect on metabolite concentrations (Study III).  
When the insulin-mimetic agent vanadate was infused into human skeletal muscle 
(Study IV), it was found to decrease the interstitial glucose concentration in a similar 
way as insulin, but in contrast to insulin, the effect of vanadate was not diminished in 
insulin-resistant skeletal muscle and was not affected by exercise (Study V). 
In insulin-resistant human skeletal muscle, the effect of insulin tended to be larger 
following a single 2-h bout of exercise than in resting muscle (-32 % versus -20%, 
p<0.09) (Study V). The insulin effect in resting muscle of healthy individuals was –30 
% (Study III).  
In conclusion, the studies in the present thesis support the hypothesis that it will be 
possible in the future to measure insulin resistance in skeletal muscle with 
microdialysis and to use the technique to explore the effect on skeletal muscle of 
different therapeutic options in the treatment of type-2 diabetes. On this line, the 
present results indicate that a single bout of exercise normalizes the insulin effect on the 
interstitial glucose concentration in insulin-resistant human skeletal muscle. 
 
Key words: microdialysis, human skeletal muscle, glucose, lactate, pyruvate, glycerol, 
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 INTRODUCTION 
 
Through the degradation of carbohydrates, proteins and lipids, energy is released and 
available to use, e.g. in a muscle contraction or for synthesis of compounds. The energy 
that is not used at once is stored, mainly as triglycerides in the adipose tissue (Cahill, 
1970) or as glycogen in the skeletal muscle and in the liver (Felig, 1976; Hultman, 
1971). The energy liberating reactions are often coupled to the energy demanding ones. 
The interplay between those processes is what we call metabolism. Energy homeostasis 
is achieved when the metabolism is in balance.  
  
 SKELETAL MUSCLE METABOLISM 
Cells in human skeletal muscle use, as most cells, ATP as energy source and generate 
ATP mostly from oxidation of glucose and free fatty acids (FFA). When glucose enters 
the cell it is either stored as glycogen or undergoes glycolysis. The fate of glucose is 
determined by the energy demand on the cell. Glucose initially stored as glycogen can 
later undergo glycogenolysis/glycolysis. Pyruvate, the end product of glycolysis, can 
then be oxidized aerobically via the Krebs cycle or converted to lactate. The glycolysis 
net yield of energy is 2 moles of ATP per mole of glucose (or 3 if the glucose is derived 
from cell glycogen) and the Krebs cycle net yield is 36 moles ATP/mole glucose. The 
energy yield from FFAs varies with its size. The most abundant fatty acid in the body, 
palmitate, yields 129 ATP (Devlin, 1998).  
Glucose entry into cells is not a process of simple diffusion; it requires the involvement 
of a carrier protein in order to facilitate the movement of glucose across the plasma 
membrane. In skeletal muscle cells the predominant carrier protein is GLUT4. If the 
skeletal muscle cell is stimulated by insulin or exercise, GLUT4 is translocated from 
intracellular pools to the plasma membrane and thus facilitates glucose to enter the cell.  
  
 MICRODIALYSIS 
 Background 
The history of microdialysis goes back to the early work of Bito et al (Bito, 1966) and 
Delgado et al (Delgado, 1972). Ungerstedt and Pycock (Ungerstedt, 1974) refined and 
developed the microdialysis sampling technique in vivo in brain tissue. From the early 
applications in monitoring neurochemical events in animals, the use of microdialysis 
has been spread to many other areas of research including measurements in adipose 
tissue (Arner, 1990; Lönnroth, 1987), blood (Arner, 1988), ocular tissues (Ben-Nun, 
1989; Waga, 1991), spinal cord (Backström, 2001), pancreas (Stock, 1990), skeletal 
muscle (Henriksson, 1990), tumors (Palsmeier, 1994), myocardium (Kuzmin, 1992; 
Zemgulis, 2001), skin (Anderson, 1992; Petersen, 1992), liver (Scott, 1993), spleen 
(Shimizu, 1994), bone (Stolle, 2003; Thorsen, 1996), intestine (Oldner, 1996; 
Tenhunen, 1999), tendon (Langberg, 1999), lungs (Herkner, 2002; Oldner, 1999) and 
joints (Lawand, 2000).  
Important reasons for the attractiveness of microdialysis are the atraumatic character as 
well as the possibility to sample from the interstitium rather than from the often less 
relevant blood compartment (Bolinder, 1993; Lönnroth, 1987). Another advantage with 
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microdialysis is that it is possible to analyze the sample immediately, without further 
purification. This is due to the fact that only low molecular weight substances pass the 
membrane, thus the sample is clean and can be used in most assays without further 
treatment. In addition, biologic compounds in the sample are protected from enzymes 
which cannot pass the microdialysis membrane. Microdialysis has also been used in 
several clinical studies (reviewed in Klaus, 2004).  
 
 Principle of microdialysis 
The basic principle of microdialysis is to mimic the passive function of a capillary 
blood vessel. The microdialysis device consists of a catheter which in the distal part has 
a tubular dialysis membrane permeable to water and small solutes. The catheter is 
inserted into the tissue and continuously perfused with a solution that resembles the 
interstitial fluid. Through connective tubing, perfusion fluid is pumped through the 
catheter with a perfusion pump. The perfusion fluid that has passed the membrane, 
named dialysate, is collected at the end of the outlet tubing in a microvial and analyzed 
chemically. When the perfusion fluid passes the membrane it equilibrates with the fluid 
outside the membrane by diffusion in both directions. The composition of the dialysate 
therefore reflects the composition of the interstitial fluid of the tissue being sampled.  
 
 Calibration 
When microdialysis is not performed under equilibrium conditions, the dialysate 
concentrations are only a fraction of the interstitial concentration. In this case 
calibration is a prerequisite. The ratio between the concentration of a particular 
substance in the dialysate and the interstitial concentration of the same substance is 
defined as the relative recovery in microdialysis experiments. The calibration 
procedure aims at finding out the relative recovery of the metabolite of interest.  
 
 Recovery 
In addition to relative recovery, absolute recovery sometimes needs to be considered in 
microdialysis experiments. Absolute recovery is defined as the total amount of the 
substance harvested in the outflow per unit time. If the concentration of a substance 
outside the catheter is increased, more of the substance will diffuse over to the perfusate 
since the concentration gradient is changed. This results in an unchanged relative 
recovery but an increased absolute recovery. Relative recovery can be considered to be 
constant as long as the diffusion conditions are the same, while the absolute recovery 
varies with the interstitial concentration of the substance. The recovery is influenced by 
various factors:  
 
Perfusion flow rate 
Absolute recovery decreases and relative recovery increases non-linearly when 
perfusion flow decreases (Benveniste, 1989). With very low perfusion flow rates, the 
relative recovery may approach 100 % (Alexander, 1988; Menacherry, 1992). In this 
thesis we show that with very low perfusion flow rate that it is possible to reach full 
equilibration between interstitial and perfusion fluids. The relative recovery is then 100 
%. 
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Area of the dialysis membrane 
Both absolute and relative recovery increases proportionally when the effective surface 
area of the dialysis membrane is increased (Benveniste, 1989). When designing a 
microdialysis experiment, the perfusion flow rate and the membrane area are the two 
possible ways of influencing the relative recovery. Usually the limiting factor is the 
sample volume required for analyzing the metabolite of interest. A low perfusion flow 
rate gives a high relative recovery and low absolute recovery, thus minimizing the 
amount of drainage of substances from the tissue, but requires longer collections times.  
 
Speed of diffusion within the tissue 
Diffusion in an inhomogeneous tissue is impeded by cell membranes which will give 
rise to a prolongation of the diffusion pathway (compared to the in vitro situation). This 
is probably the major rate-limiting factor in microdialysis measurements rather than the 
passage through the dialysis membrane (Amberg, 1989). Diffusion is also dependent on 
the radius of the solute. The diffusion coefficient is inversely proportional to the radius 
and hence also to the molecular weight of the solute (Benveniste, 1989).  
 
Properties of the dialysis membrane 
Certain substances may adhere to or interact with the membrane via unknown 
mechanisms and this affects the recovery (Benveniste, 1989). The microdialysis 
membranes are available with different molecular weight cut-offs and this obviously 
determines the size of the substance that can be recovered.  
 
Tissue temperature 
The relative recovery is directly related to the temperature of the tissue. The diffusion 
coefficient is increased at a higher temperature (Benveniste, 1989). This should 
especially be taken into consideration when in vitro recovery is determined. In the in 
vivo situation a perfusate solution at room temperature (instead of body temperature) 
does not seem to affect metabolite concentration as long as the solution is not hypotonic 
(de Lange, 1994).  
 
 No-net flux method 
One method to estimate the in vivo recovery is the no no-net-flux method, introduced 
by Lönnroth et al (Lönnroth, 1987). The procedure involves perfusing the same 
compound at several different concentrations through the microdialysis catheter when it 
is inserted in the tissue. Selected concentrations should be above and below the 
expected interstitial concentrations. The difference between the concentrations in 
dialysate and perfusate is plotted in a graph against the concentration of the compound 
in the perfusion medium. Using linear regression it is possible to calculate the point 
where no diffusion occurs (no-net-flux). At this point, when the concentrations in 
dialysate and perfusate are equal, the concentration in the perfusion medium is the same 
as the interstitial concentration. The slope of the regression line provides the recovery. 
Interstitial concentration has to be stable during calibration and the recovery assumed 
not to change during the experiment. The method is very time consuming and therefore 
most suitable as a reference method when evaluating other calibration techniques. 
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 Zero-flow method 
Another calibration method is the zero-flow method (Bungay, 1990; Ekblom, 1992; 
Jacobson, 1985). The perfusion flow rate is varied and the different dialysate 
concentrations are plotted, then using non-linear regression analysis to extrapolate to 
zero flow, the recovery is determined. At zero flow the relative recovery will be 100 %. 
This method has about the same advantages and disadvantages as the no-net-flux 
method although the zero-flow method is more mathematically demanding.  
 
 Retrodialysis 
The method of retrodialysis or internal reference technique (Jansson, 1994; Larsson, 
1991; Scheller, 1991) consists of adding a marker to the perfusate. The marker should 
be a compound with diffusion characteristics close to the substance of interest, most 
commonly it has been a labeled analogue. The recovery in vivo can be achieved after 
measuring the relative loss of a substance diffusing from the perfusate to the interstitial 
fluid. It is assumed that the flux over the membrane is equal in both directions and that 
the marker has similar diffusion properties as the substance sampled from the 
interstitial fluid. A major advantage with this method is that the recovery can be 
measured continuously and at the same time as the experiment.  
 
 Near-equilibrium 
When the perfusion flow rate is very low and the membrane is long, the recovery is 
assumed to be near 100 % (Alexander, 1988; Bolinder, 1992; Hagström-Toft, 1997; 
Menacherry, 1992; Moberg, 1997). The concentrations on both sides of the membrane 
then have time to equilibrate totally. No calculations are needed and the true interstitial 
concentration is measured directly. The amount of sample obtained is relatively small 
though and therefore requires relatively long sampling periods. A positive feature with 
this technique is that the absolute amount of substances drained from the tissue is kept 
at a minimum. When microdialysis is performed at high flow rates, a concentration 
gradient can develop which depletes the interstitial compartment of the compound of 
interest.  
The near-equilibrium technique seemed to be ideal for our experiments. The papers 
included in this thesis are based on that method. 
 
 Colloid 
To make sampling at low perfusion flows possible in skeletal muscle, without a 
substantial loss of perfusate into the tissue, a colloid needs to be included in the 
perfusion fluid (Rosdahl, 1997). In the referred study it was shown that when dextran-
70 at 40 g/L is used, no net loss of perfusate occurs, even if the perfusion flow is as low 
as 0.16 µL/min (Rosdahl, 1997). When the membrane of the microdialysis catheter has 
a higher molecular cut-off (larger pore-size), the use of a colloid or a push-pull 
pumping setup is necessary even at higher perfusion flow rates to prevent fluid loss 
(Hoffner, 2003; Sjögren, 2002). If the interstitial pressure decreases in the tissue there 
will also be a fluid loss if the perfusion fluid is not supplemented with a colloid 
(Langberg, 1999). 
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 Microdialysis in the human skeletal muscle 
It was reported in 1993 that microdialysis can be used successfully in human skeletal 
muscle (Rosdahl, 1993). Since then microdialysis in human skeletal muscle has been 
used to measure absolute concentrations of glucose, lactate, glycerol, urea, pyruvate, 
thromboxane, amino acids, insulin, prostaglandin, adenosine, AMP, ADP, ATP, 
purines, choline, potassium, glutathione vascular endothelial growth factor (VEGF), 
creatine, neuropeptide Y and calcium (Ernberg, 2004; Frandsen, 2000; Green, 1999; 
Gutierrez, 1999; Hagström-Toft, 1997; Hellsten, 1998; Hoffner, 2003; Korth, 2000; 
Lundberg, 2000; Müller, 1995; Persky, 2003; Samii, 2004; Sjöstrand, 1999; 
Tonkonogi, 2003) as well as blood flow (Hickner, 1994). Most experiments have been 
performed in resting skeletal muscle but in some investigations static (Green, 1999; 
Rosdahl, 1993) or dynamic muscle contractions (Hellsten, 1998; Juel, 2000)(Reviewed 
in (Bangsbo, 1999) were also studied.  
 
 Effect of catheter insertion 
The microdialysis technique involves the introduction of a foreign material into a 
tissue. The response to implantation of a microdialysis catheter can broadly be 
classified as; trauma caused by guide or catheter insertion, effects on the vascular 
system over a wider area and inflammatory reactions to the catheter (Anderson, 1994). 
Most studies investigating the effect of catheter insertion have been performed in rat 
brain or human skin. In the rat brain there are changes in both local glucose metabolism 
and blood flow within three hours following insertion. These changes are not seen 24 
hours after insertion though (Benveniste, 1989). Signs of lesions in the blood-brain 
barrier in the rat brain undergoing catheter insertion are seen 10 – 30 min following 
implantation, but not thereafter. These effects may be due to changes that are 
specifically associated to the brain metabolism and does not necessarily have to occur 
in skeletal muscle. Around catheters inserted into human skin investigators have seen 
an increased blood flow immediately after insertion, which had nearly normalized after 
60 min (Anderson, 1994). Groth et al (Groth, 1998) have suggested that an 
equilibration period of 90 – 120 min is required after catheter insertion in human skin. 
To reduce the effect of insertion, local anesthesia is furthermore suggested prior to 
insertion (Anderson, 1994). Histological examination of rat skeletal muscle at 1, 6, 12 
and 32 hours after catheter insertion reveals very little damage. No pocket of extra 
cellular fluid and no evidence of bleeding were found. Infiltration of lymphocytes could 
be seen beginning at six hours and continued over the next 24 hours but no 
morphological changes were seen and the lymphocyte infiltration did not affect the 
recovery over the dialysis membrane (Palsmeier, 1994). Levels of glutathione were 
high immediately after implantation in rat skeletal muscle and declined to steady state 
levels after 90 min (Sirsjö, 1996). The insertion of a catheter in human skeletal muscle 
results in leakage of glycerol from muscle cells to the interstitial space causing a rise in 
interstitial concentration of glycerol. High glycerol concentration and elevated amino 
acid concentrations in human skeletal muscle caused by cellular damage imply that a 
period of rest of at least 90 – 150 min from insertion of the catheter is required before 
baseline collection starts (Gutierrez, 1999).  
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 INSULIN SENSITIVITY 
Plasma glucose is tightly regulated around an average concentration of 4.5 mM in 
healthy humans. When the concentration falls below 3.3 mM, central nervous system 
function becomes progressively impaired and death may ensue (Berne, 1993). A high 
concentration of glucose in the blood is a characteristic feature of diabetes mellitus and 
can also be a risk factor for a number of complications including cardiovascular 
diseases, cerebrovascular diseases and neoplasms (Balkau, 1998). The key hormone 
regulating blood glucose levels is insulin. Insulin affects almost every type of cellular 
function ranging from acute metabolic effects, including glucose transport and 
inhibition of lipolysis, to long term cell growth and division. Regarding blood glucose 
levels, skeletal muscle is one of three organs that, above all, respond to insulin in a way 
that markedly influences the blood glucose concentration. Of these organs skeletal 
muscle is quantitatively the largest tissue involved in maintaining glucose homeostasis 
(DeFronzo, 1988). The skeletal muscle is also able to take up glucose in response to 
exercise (contractile activity) without involving insulin. An exercise session therefore 
increases the glucose transport activity specifically to the active tissue and this is 
associated with a transient decline in circulating insulin levels during endurance 
exercise (Short, 1997). In exercised trained people the circulating levels of insulin are 
furthermore decreased at rest in response to e.g. oral glucose (Mikines, 1989). Exercise 
trained people therefore need less insulin in order to maintain glucose homeostasis– 
their insulin sensitivity is increased. The insulin sensitivity increases with increasing 
amount of physical activity. This increased sensitivity applies especially to the skeletal 
muscles involved in the exercise (Mikines, 1989). This may be one factor explaining 
why physical activity is one of the best methods to decrease the risk of developing 
cardiovascular diseases.  
 
 Insulin resistance 
The opposite of insulin sensitivity is insulin resistance and this can be defined as a 
condition where insulin is unable to exert a normal biological response in its target 
tissues. Insulin resistance is a well known risk factor in cardiovascular disease and 
together with abdominal obesity, is often referred to as the metabolic syndrome or 
insulin resistance syndrome (Reaven, 1988). Insulin resistance is also a prominent 
feature of individuals with Type II diabetes mellitus. Development of insulin resistance 
in skeletal muscle precedes the development of Type II diabetes mellitus (Vaag, 1992).  
The patophysiological mechanisms of insulin resistance are poorly understood. There 
are a number of sites in the body where the resistance can occur; in the pancreas, from 
where the insulin is released, somewhere along the route of transport to the tissues (e.g. 
the capillary wall), in the liver (which then liberates too much glucose), the muscle or 
fat cell membrane (e.g. lack of receptors) or inside the muscle or fat cell (abnormal 
signal transduction). Also overproduction of FFAs from the adipose tissue and 
adipocyte overexpression of tumor necrosis factor-α (TNF-α) have been implicated to 
cause insulin resistance (Hotamisligil, 1995; Shulman, 1999). The insulin resistance 
causes an increased insulin secretion from the β-cells in the pancreas resulting in 
hyperinsulinemia. This means that the abnormality in insulin-resistant states can be due 
to the insulin resistance itself or chronic effects of compensatory hyperinsulinemia 
(Ferrannini, 1998). 
 
   7 
 Measuring insulin resistance in vivo 
Since insulin resistance is one of the earliest signs of cardiovascular risk and Type II 
diabetes mellitus there is a need for an accurate and reproducible method for measuring 
insulin resistance in vivo. At a whole body level, based on peripheral blood sampling, 
any insulin effect is a compound effect induced in various tissues. This is probably the 
reason why several techniques to measure insulin resistance in vivo have been devised.  
There is a general agreement that the glucose clamp technique (DeFronzo, 1979) is the 
golden standard for measurement of insulin action. With this technique insulin is 
infused at a constant preset rate and the plasma glucose concentration is clamped at the 
normal fasting (5 mM, euglycemic) or any pre-existing (isoglycemic) level. The 
glucose concentration in plasma is held constant via glucose infusion through an 
adjustable pump and blood is drawn at regular intervals (normally every fifth minute) 
to measure plasma glucose concentration. When a steady state is attained, the glucose 
infusion rate equals the amount of glucose disposed of by all the tissues in the body 
which is a measure of overall insulin sensitivity.  
A more indirect method is the oral glucose tolerance test (OGTT). The technique is 
much less demanding than the glucose clamp technique; it provides information about 
insulin secretion and action but does not directly yield a measure of insulin sensitivity. 
The subject drinks a solution of 75 g glucose mixed in (250 ml) water. Blood samples 
are collected before drinking the solution and thereafter every 30 min for two to three 
hours for the measurement of plasma glucose and insulin. This test is widely used in the 
clinic to diagnose Type II diabetes. The diagnostic criteria for diabetes is a fasting 
blood (venous) glucose > 6.1 mM and/or a 2-hours post load concentration of >10.0 
mM (WHO, 1999). Impaired glucose tolerance is said to occur if the 2-hours post load 
concentration is > 6.7 mM (WHO, 1999).  
All methods available today to measure insulin resistance determine the whole body 
insulin resistance. A method to measure the local insulin resistance in a single tissue 
would be interesting in evaluating the origin of insulin resistance. The hypothesis 
behind the studies in this thesis is that it will be possible in the future to measure insulin 
resistance with microdialysis. 
 
 Insulin adsorption of plastic tubing 
When handling insulin in a solution it is important to be aware that insulin is known to 
be adsorbed by different materials such as glass and polyacrylamide (Petty, 1974). It 
seems as if the adsorption varies inversely with the concentration of insulin in the 
solution (Hirsch, 1977). It is also known that albumin may have a protecting effect in 
reducing the insulin adsorption (Schildt, 1978). This is the reason why a small amount 
of the patient’s own blood is added to the insulin solution when performing a glucose 
clamp experiment (DeFronzo, 1979).  
The extent of adsorption to tubing is determined by a drug’s diffusion coefficient, the 
length of tubing and the solution flow rate (Elliott, 1980). The amount of insulin 
adsorption to the membrane of a microdialysis catheter has not, to our knowledge, been 
examined. This should therefore be investigated more thoroughly before continuing 
examinations of giving insulin via the perfusion solution of a microdialysis catheter.  
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 VANADATE 
Vanadium is a trace element that occurs in concentrations ranging from 0.1 to 3 nmol/g 
(Post, 1979) in most mammalian cells. The physiological role of vanadium is not 
known, but it seems to be needed for normal growth and development (Nechay, 1984). 
Vanadate, the salt of vanadium, which resembles phosphate structurally, has in recent 
years been demonstrated to mimic most of the biological effects of insulin in several 
cell types (Shechter, 1990). This makes vanadate a potential therapeutic tool of clinical 
interest in diabetes mellitus type-2. 
In skeletal muscle most studies report that vanadate stimulates the glucose uptake 
through a different signaling pathway than insulin. Available data indicate that this 
pathway resembles that of the hypoxia-induced glucose transport (Cortright, 1997). In 
human skeletal muscle in vitro, vanadate stimulates glucose transport both in insulin-
resistant (Carey, 1995) and insulin-sensitive muscle (Cortright, 1997). However, 
concerning the function of vanadate in human skeletal muscle in vivo, no information is 
available. 
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 AIMS 
Microdialysis gives a unique possibility to study metabolic events in the interstitial 
water space in vivo. The technique can be applied in many ways. One way is to 
monitor the concentration of small molecules in a tissue and compare this with the 
concentration in blood to evaluate the contribution of that tissue to the metabolism of 
the molecule. Another way to use microdialysis is to add a drug or a hormone to the 
perfusion fluid, which does not cause generalized effects, and study the specific effect 
on that tissue. Focusing on methodological and physiological aspects, the general aim 
of this thesis was to investigate the possibility of using microdialysis in vivo, in human 
skeletal muscle, to study glucose metabolism, with special reference to insulin 
resistance and exercise. The specific aims were: 
 
I. to examine the use of a very low perfusion flow rate in microdialysis in order 
to directly measure interstitial concentrations of the metabolites glucose, 
lactate, glycerol and urea. 
 
II. to examine the effect (on metabolites and collected volume) of adding a 
colloid to the microdialysis perfusion solution (a colloid being necessary for 
avoiding fluid loss at a very low perfusion flow rate). 
 
III. to determine if it is possible to give insulin through the microdialysis catheter 
to study the local insulin sensitivity in human skeletal muscle by measuring 
the interstitial glucose concentration. 
 
IV. to determine the local effect of the insulin-mimetic compound vanadate on 
glucose metabolism in human skeletal muscle and examine if it is possible to 
use vanadate in combination with microdialysis as a measure of insulin 
resistance. 
 
V. to examine the local effect of insulin and vanadate on glucose metabolism in 
insulin resistant human skeletal muscle in the control state and after a single 
bout of exercise 
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 MATERIALS & METHODS 
 
 SUBJECTS 
Table 2.Characteristics of subjects participating in the experiments. Values are mean ± 
SEM.  
Study Number of subjects Age Height (m) Weight (kg) 
I 18 24.9 ± 0.9 180 ± 1.9 79.7 ± 2.6 
II 13 24 ±2.8 182 ± 0.02 77.7 ± 2.7 
III 13 29 ± 2.7 183 ± 1 77 ± 2.0 
IV 13 26.6 ±1.6 1.79 ±0.02 74.8 ± 2.9 
IV 5 54.2 ±7.9 1.86 ±0.03 118.8 ± 6.3 
V 8 51.5 ±2.1 1.78 ±0.02 100.5 ± 5.76
 
 
 MICRODIALYSIS  
 Catheters 
All catheters used consisted of polyurethane tubing and a polyamide dialysis 
membrane. The catheters are needle-shaped with a double lumen cannula and a hollow 
fiber membrane at its tip (distal part). The molecular cut-off point for the dialysis 
membranes were 20 kDa in study I – V and also 100 kDa in study III – V. The length 
of the dialysis membrane was always 30 mm. The 20 kDa catheters used were CMA 60 
(study I – V), figure 1, and the 100 kDa catheters were either CMA 60 (study III and 
IV) or CMA 71 (study V), all obtained from CMA Microdialysis AB, Stockholm, 
Sweden. In study III the microdialysis catheters were equipped with two inlet tubings.  
 
 Insertion of microdialysis catheters 
Before insertion a local anaesthetic (0.3 ml of 1 % Carbocain, Astrazeneca, Södertälje, 
Sweden) was given subcutaneously and above the muscle fascia. Insertion of the 
catheters was performed using a steel-guide cannula or a guide tubing. In the steel 
guide procedure, the catheters were placed in a steel guide cannula when inserted; 
thereafter the steel guide cannula was instantly removed leaving the microdialysis 
catheter in place in the tissue. In the guide tubing procedure, a steel cannula with plastic 
tubing fitted on the outside was inserted in the tissue followed by immediate 
withdrawal of the steel cannula, leaving the tubing in place in the tissue. The 
microdialysis catheter was inserted in the tubing which then was removed by splicing 
upon retraction.  
 
 Perfusion fluid 
The fluid used for perfusion of the catheters was a modified Krebs-Henseleit buffer 
(KHB). The bicarbonate was replaced with phosphate in order to achieve a stable pH in 
room temperature (Hickner, 1992). In all studies, except for half of the catheters in 
study II, the perfusion fluid was supplemented with dextran-70 in order to prevent fluid 
loss. In study III and V the perfusion fluid in some catheters were supplemented with 
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insulin and in study IV and V the fluid in some catheters were supplemented with 
vanadate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Microdialysis catheter (CMA 60). The catheter consist of a 30 mm long 
polyamide dialysis membrane (o.d. 0.52 mm), outer shaft tubing (polyurethane, o.d. 0.8 
mm, length 20 mm), inlet tubing (polyurethane, o.d. 1.0 mm, i.d. 0.15 mm, length 400 
mm), and outlet tubing (polyurethane, o.d. 1.0 mm, i.d. 0.15 mm, length 105 mm).  
 
 
 Perfusion flow rate 
In all studies a very low perfusion flow rate was used in order to achieve complete 
equilibration between interstitial and perfusion fluids (0.16 – 0.2 µl/min). In study I a 
protocol with successively lower perfusion flows down to 0.075 µl/min were used in 
order to identify the perfusion flow rate where complete equilibration occurs. In study 
III and V a higher perfusion flow rate (1.33 µl/min) was used for the insulin catheters 
and their respective control catheters in order to prevent total adsorption of insulin in 
the plastic tubing and dialysis membrane. The pumps used were either CMA 100 or 
CMA 106 (CMA Microdialysis AB, Stockholm, Sweden) 
 
 BIOCHEMICAL ANALYSIS 
 Analysis of dialysate samples 
The concentrations of glucose, lactate, glycerol, pyruvate and urea in the microdialysis 
samples were analyzed on CMA 600 Microdialysis Analyzer, using ordinary enzymatic 
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methods. The sample (0.2 – 0.5 µl) and reagent volumes (14.5 – 14.8 µl) are handled 
by a high-precision pipetting device. The rate of formation of the red-violet substance 
quinoneimine is measured in a filter photometer at 546 nm for glucose, lactate, glycerol 
and pyruvate. For urea, the rate of utilization of NADH is measured at 365 nm. By 
extracting the maximal absorbance change per second from the generated absorbance 
versus time curve, the instrument performs a kinetic measurement. Depending on the 
substance being measured, the complete measurement cycle takes between 60 and 120 
s. The used reagents were obtained from CMA microdialysis and controls were 
included at regular intervals. 
The concentration of insulin in the microdialysis samples was analyzed with a double-
antibody radioimmunoassay (Pharmacia, Uppsala, Sweden).  
The concentration of ethanol was determined using a modification of the procedure 
described by Bernt & Gutmann (Bernt, 1974). The analyses were made within one day 
of the experiment and are described more thoroughly in Rosdahl et al 1993 (Rosdahl, 
1993).  
 
 Analysis of plasma samples 
The plasma samples were analyzed using colorimetric methods on a Cobas Mira-s 
clinical analyzer (Roche Diagnostics, Basel, Switzerland). Earlier, verification between 
concentrations from the Cobas Mira-s analyzer and the CMA 600 analyzer was made to 
ensure that the concentrations are comparable (Rosdahl, 1998). 
 
 ORAL GLUCOSE TOLERANCE TEST 
After an overnight fast the subjects in study V (and the insulin-resistant subjects in 
study IV) had a catheter inserted in an antecubital vein which was kept patent by a slow 
infusion of saline. The subjects were then given 75 g glucose in 250 – 300 ml water to 
drink over the course of five minutes. Blood samples were taken before the glucose 
load and at time 30, 60, 90 and 120 min after the glucose ingestion for plasma glucose 
and insulin measurements (WHO, 1999). The determination of blood glucose 
concentration were made using FreeStyle (TheraSense, USA). Subjects that had blood 
glucose concentrations (venous) above 6.7 mM (but below 10.0 mM) two hours after 
glucose ingestion (WHO, 1999) were included in the study. Subjects that according to 
the HOMA model (Homeostasis model assessment; fasting insulin (µU/ml) × fasting 
glucose (mM)]/22.5) (Matthews, 1985) were insulin resistant (Nakai, 2002) were also 
included in the study. 
 
 
 STATISTICS 
All values are given as means ± SEM (standard error of mean) except for paper IV, 
were the values are given as medians ± SD (standard deviation). This was due to the 
smaller number of subjects in each group in this study. The statistical significance was 
determined with Student’s t-test for paired comparisons or one, two or three-way 
ANOVA with repeated measures design as indicated in the articles. 
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 RESULTS  
 METABOLITE LEVELS IN HUMAN SKELETAL MUSCLE AND 
ADIPOSE TISSUE (STUDY I) 
 Experimental design 
This study was designed to investigate if it was possible to identify a perfusion flow at 
which the interstitial fluid in human skeletal muscle and adipose tissue completely 
equilibrated with the microdialysis perfusion fluid. The metabolites studied were 
glucose, lactate, glycerol and urea. 18 male subjects had microdialysis catheters 
inserted in the vastus lateralis of the quadriceps femoris muscle and subcutaneous 
adipose tissue. Experiments with successively lowered perfusion flow rate were 
performed; 1.33 – 0.16 µl/min as flow rates in 13 subjects and 0.33 – 0.075 µl/min in 
five subjects.  
 
 Results  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Glucose, lactate, glycerol and urea concentrations in venous plasma and 
microdialysis samples from skeletal muscle and adipose tissue with perfusion flow 
rates 1.33 – 0.16 µl/min.  
 
 
A metabolite was considered completely equilibrated if the concentration did not 
increase when the perfusion flow rate was decreased. The glucose concentration was 
equilibrated completely at 0.16 µl/min in both tissues, since the glucose concentration 
did not differ between 0.16 µl/min and 0.075 µl/min. The lactate concentration was 
equilibrated at 0.33 µl/min, the glycerol concentration at 0.66 µl/min in skeletal muscle 
and 0.33 µl/min in adipose tissue and the urea concentration equilibrated at 0.33 µl/min 
in skeletal muscle and at 0.16 µl/min in adipose tissue. 
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 Conclusion 
We did show that it is possible to find a perfusion flow at which the interstitial fluid in 
human skeletal muscle and adipose tissue completely equilibrates with the 
microdialysis perfusion fluid. At complete equilibration, the measured concentrations 
of glucose, glycerol and urea were in good agreement with expected tissue levels. 
Overall, the study indicates that microdialysis at a low perfusion flow may be a tool for 
continuous monitoring of tissue interstitial concentrations. 
 
 EFFECTS OF ADDING A COLLOID TO THE MICRODIALYSIS 
PERFUSATE (STUDY II) 
 Experimental design 
In this study we investigated the effect of changes in colloid osmotic pressure and in 
hydrostatic pressure of the perfusion solution on net fluid transport across the 
microdialysis membrane and on metabolite concentrations in the dialysate.  
Changes in the hydrostatic pressure were induced by varying the vertical position of the 
outflow tubing. Changes in osmotic pressure were induced by using perfusate with or 
without dextran-70. The experiments were performed both in vitro (the catheters placed 
in vials containing KHB with glucose, lactate, glycerol and urea) and in vivo (in the 
vastus lateralis of the quadriceps femoris muscle) in 13 male subjects.  
 
 Results 
The sample volumes were significantly smaller in catheters perfused without a colloid 
compared with those perfused with a colloid. The sample volumes were also 
significantly smaller when the outflow tubing was influenced by maximal hydrostatic 
pressure (above position) compared with minimal hydrostatic pressure (below 
position). In vivo, glucose concentration at 0.33 µL/min was higher when the catheters 
were perfused without a colloid than with a colloid. There was a tendency to a 
corresponding difference also in lactate, glycerol and urea. At 0.16 µL/min, the glucose 
concentration was the same irrespective of if fluid loss had been counteracted by 
colloid inclusion or by lowering of outlet tubing.  
The mechanisms behind the difference in the glucose concentration at 0.33 µl/min are 
thought to be 1) a higher effective perfusion flow rate when dextran-70 is added and 2) 
that the recovery of glucose is lower than for the other metabolites. Glucose is therefore 
more affected by changes in flow rate at flow rates where the concentrations in the 
interstitial and perfusion fluids are not yet equilibrated. 
 
 Conclusion 
This study illustrates that both hydrostatic and osmotic pressures determine the net fluid 
transport across the dialysis membrane of a microdialysis catheter, both in vitro and in 
vivo in human skeletal muscle. Fluid balance could be achieved in this study by adding 
a colloid (dextran-70) to the perfusate or by maximally lowering an extended outflow 
tubing. This study shows that fluid imbalances can have important implications for 
microdialysis results at low perfusion flow rates. 
  
   15 
 INSULIN INDUCES LOCAL METABOLIC EFFECTS IN HUMAN 
SKELETAL MUSCLE WHEN PERFUSED THROUGH A 
MICRODIALYSIS CATHETER (STUDY III) 
 
 Experimental design 
In this study the aims were 1) to examine the use of a large pore size dialysis membrane 
in human skeletal muscle 2) if dextran-70 could be used to prevent fluid loss with these 
membranes 3) if these membranes could be used to study interstitial concentrations of 
metabolites in skeletal muscle and 4) if it is possible to deliver insulin to the skeletal 
muscle and monitor its local effect on glucose transport.  
Microdialysis catheters (CMA 60 with a 100 kDa mol. wt. cut-off dialysis membrane) 
were inserted in the quadriceps femoris muscle of 13 male subjects. In four subjects the 
catheters were perfused with succesively lower flow rates (1.33 – 0.16 µl/min), in nine 
subjects the perfusion fluid to one catheter was supplemented with insulin at a 
successively increasing concentration.  
 
 Results 
With different perfusion flow rates the recorded concentrations of glucose, lactate, 
glycerol and urea were in agreement with previously obtained values using a 
conventional membrane with a smaller pore size (20 kDa) (Study I). 
When insulin was added to the perfusate the concentration of glucose was significantly 
reduced whereas no changes occurred in the control catheter. 
 
 Conclusion 
This study shows 1) that the loss of perfusate from microdialysis catheters with a 100 
kDa dialysis membrane can be prevented if a colloid is added to the perfusate and that 
this membrane is suitable for recordings of molecules in the interstitial space and 2) 
that large peptide molecules such as insulin diffuses across the dialysis membrane and 
has cellular effects that can be simultaneously recorded. 
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Figure 3. Glucose, lactate and urea concentrations presented as percent change from 
basal, in microdialysis samples from the insulin infusion experiment. Following a 
basal period, one catheter was perfused with a stepwise increased concentration of 
insulin while the other catheter served as control.  
 
 
 LOCAL EFFECT OF VANADATE ON INTERSTITIAL GLUCOSE AND 
LACTATE CONCENTRATIONS IN HUMAN SKELETAL MUSCLE 
(STUDY IV) 
 Experimental design 
Study IV was undertaken to investigate the effect of the insulin-mimetic trace element 
sodium metavanadate on interstitial glucose and lactate concentrations in human 
skeletal muscle in vivo.  
Interstitial concentrations of glucose and lactate were determined by microdialysis at a 
low flow rate in the quadriceps femoris muscle of 18 men. In the same leg two 
microdialysis catheters were inserted. In one catheter, the perfusion medium was 
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supplemented with sodium metavanadate (10-100 mM) after a basal period, the other 
catheter served as control.  
 
 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The effect (in percent) of perfusion with vanadate (10-100 mM) through 
microdialysis catheters placed in skeletal muscle of healthy human subjects on glucose (left), 
lactate (middle) and urea (right) concentrations in collected microdialysis samples. Each 
point represents one subject, with a comparison between one vanadate and one control 
catheter. 
 
 
In the catheter perfused with metavanadate, the interstitial glucose concentration was 
decreased by 13 – 50 % compared to the control catheter (p<0.05). The lactate 
concentration was higher in the 50 mM and 100 mM metavanadate catheters compared 
to control (39 – 89 %, p<0.05). There was no difference between control and 
metavanadate catheters in urea concentrations. Five of the subjects were insulin-
resistant and for them the results were similar, although the effect was somewhat 
smaller.  
 
 Conclusion 
Perfusion with vanadate through microdialysis catheters in human skeletal muscle 
results in a decreased interstitial glucose concentration and an increased lactate 
concentration. This study thus indicates that vanadate mimics the effect of insulin in 
human skeletal muscle in vivo.  
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 LOCAL EFFECT OF INSULIN AND VANADATE IN INSULIN-
RESISTANT HUMAN SKELETAL MUSCLE: INFLUENCE OF A 
SINGLE BOUT OF ONE-LEGGED EXERCISE (STUDY V) 
 Experimental design 
Study V was designed to test the hypothesis that a single bout of exercise augments the 
local effect of insulin and the insulin-mimetic trace element vanadate on the interstitial 
glucose concentration in insulin-resistant human skeletal muscle.  
Eight insulin-resistant obese male subjects performed one bout (two hours) of one-
legged cycle exercise. Microdialysis catheters were then inserted in the quadriceps 
femoris muscle in both legs. The perfusion medium was supplemented, after a basal 
period, with insulin (two catheters) or sodium metavanadate (two catheters). The other 
catheters served as control.  
 
 Results 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. The glucose concentration from microdialysis catheters perfused with insulin (left), 
or vanadate (right). Open symbols are control catheters whereas filled symbols designate 
insulin/vanadate catheters, black line = working leg and grey line = resting leg. 
 
In response to exercise the glucose concentration in the previously working muscle is 
decreased during several hours post exercise. This effect is above all seen in the 
catheters perfused with a low perfusion flow rate (Figure 5 right).  
The effect of insulin on glucose concentration in the working leg (-32 %) is comparable 
with the effect seen in healthy muscle at rest (-30 %, Study III). The insulin effect in the 
resting (insulin-resistant) leg (-20 %) tended to be lower (p<0.09) than the effect in the 
working leg.  
This is quite the contrary to the effect seen after vanadate infusion, where the glucose 
concentration decreases to the same extent in both legs, and to the same or even higher 
than in healthy muscle (Study IV).  
 
 Conclusion 
A single bout of exercise normalizes the insulin effect on the interstitial glucose 
concentration in insulin-resistant human skeletal muscle. The effect of vanadate (which 
is not decreased in insulin-resistant human skeletal muscle) was not augmented by 
exercise.  
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 DISCUSSION 
 PERFUSION FLOW RATE 
To obtain diffusion equilibrium between the interstitial and perfusion fluids a very low 
perfusion flow rate is a prerequisite. Study I was performed to find out how low the 
perfusion flow rate had to be to monitor the true interstitial concentrations of glucose, 
lactate, glycerol and urea. In skeletal muscle and adipose tissue, the perfusion flow rate 
for complete equilibrium for glucose concentrations was found to be 0.16 µl/min. For 
lactate the perfusion flow rate should be 0.33 µl/min or lower, for glycerol and urea it 
should be 0.66 µl/min for complete equilibration in skeletal muscle. In adipose tissue, 
the same values were obtained except for glycerol, where the perfusion flow rate had to 
be 0.16 µl/min for complete equilibration.  
 
 Methodological variability 
One of the advantages of using a very low perfusion flow rate is the low 
methodological variability calculated from the substance concentrations in adjacent 
microdialysis catheters inserted in the same tissue. In study I we observed that the 
variability for glucose and urea was reduced when the perfusion flow rate was lowered. 
We also observed that the methodological variation was higher in adipose tissue than in 
skeletal muscle. One of the reasons for the higher variability in the abdominal adipose 
tissue could differences in skinfold thickness between subjects. In study I we found that 
the skinfold thickness was negatively correlated with recovery of glucose and urea. 
This could be due to reduced blood flow when the adipose tissue mass increases 
(Jansson, 1994).  
 
 INTERSTITIAL CONCENTRATIONS OF METABOLITES 
 Glucose 
Glucose concentration in skeletal muscle at 0.16 µl/min, and at 0.075 µl/min, was 
found to be 0.6 mM lower than the concentration in venous plasma in study I. This 
result is comparable with studies using the no-net-flux method (Müller, 1996; Müller, 
1995). In two other studies, where a perfusion flow rate of 0.3 µl/min was used the 
recovery was incomplete (but very close to 100 %) (Moberg, 1997; Rooyackers, 2004) 
which is in agreement with our results since we had to lower the perfusion flow rate 
further from 0.33 µl/min to obtain equilibrium.  
 
 Lactate 
The lactate concentration found in skeletal muscle with microdialysis is higher in our 
study (study I) than in two previous studies based on the internal reference technique 
(Holmäng, 1998; Müller, 1996), where the lactate concentration was similar to that 
measured in human muscle biopsies (Lundberg, 2002). A higher lactate concentration 
in the interstitial fluid compared to the intracellular space is however expected because 
of a higher pH in the interstitial space (Henriksson, 1999). Other studies show as high 
lactate concentrations as in the present studies (Korth, 2000; Östman, 2004). One study 
showed a higher lactate concentration than in the present studies (Axelson, 2002) 
although using the same catheters and a perfusion flow rate of 0.3 µl/min.  
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 Pyruvate 
In study V we measured the pyruvate concentration in skeletal muscle for the first time. 
The achieved pyruvate concentration is higher than previously reported in studies 
performing microdialysis in human skeletal muscle (Axelson, 2002), (Östman, 2004). 
One possible reason for this could be the use of higher perfusion flow rates in the 
referred studies. The pyruvate concentration recorded is also higher than previously 
measured in muscle biopsies (Constantin-Teodosiu, 1999) and circulating levels 
(Berne, 1993). The reason for this discrepancy could be the higher pH in the interstitial 
space, which influences pyruvate as well as lactate (see above) (Henriksson, 1999).  
 
 Glycerol 
The glycerol concentration in microdialysis samples from skeletal muscle is high 
initially which most likely is due to cellular damage caused by the insertion of the 
catheter. The glycerol concentration requires 90 – 120 min after catheter insertion to 
become stable (study I). This is in agreement with another study stating that the 
glycerol concentration should be back to baseline 90 – 150 min after insertion of the 
catheter (Gutierrez, 1999). The glycerol concentration in skeletal muscle in our studies 
are in agreement with other studies from the same muscle (Djurhuus, 2004; Hagström-
Toft, 2002). It should be noted that the glycerol concentration differ between different 
muscle groups (Hagström-Toft, 2002). 
 
 Urea 
The urea concentration in skeletal muscle in our studies is in agreement with other 
investigations (Östman, 2004). The measurement of the urea concentration was 
included since it provides information about the recovery and the diffusion condition of 
the tissue. Some investigators have attempted to use urea as a reference compound for 
in vivo calibration of the recovery of microdialysis catheters (Brunner, 2000; Ettinger, 
2001). 
 
 
 PERFUSATE LOSS 
At very low perfusion flow rates loss of fluid is a problem that must be solved in order 
to use the technique. Both hydrostatic and osmotic pressures determine the net fluid 
transport across the dialysis membrane and therefore measures to change both 
hydrostatic and osmotic pressures can be applied to create fluid balance across the 
microdialysis membrane. In this thesis the fluid loss was counteracted by adding a 
colloid (dextran-70) to the perfusion solution in all studies. Another approach to 
counteract fluid loss is to use a “push-pull” pumping system (Sjögren, 2002) instead of 
the ordinary push pumps (like CMA 100) or to apply suction to the outflow tubing 
(Hoffner, 2003). However, in spite of the inclusion of a colloid, fluid imbalances can 
influence the metabolite concentrations, as was shown in study II. To carefully control 
for fluid imbalances we always weigh the microvial before and after sample collection.  
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 INFUSION THROUGH THE MICRODIALYSIS CATHETER 
By perfusion with different hormones/drugs through the catheter, the microdialysis 
technique allows direct measurement of effects on metabolite concentrations thus 
avoiding generalized effects that can be seen in metabolic infusion studies.  
 
 Insulin 
Both in study III and V we infused insulin through the microdialysis catheter in human 
skeletal muscle and recorded a decreased glucose concentration which is assumed to 
reflect a higher rate of glucose uptake. To our knowledge this procedure has only been 
used once previously (MacLean, 2001) showing the same results.  
Before study III we performed pilot experiments where we added insulin to the 
perfusion fluid and used a low flow rate (0.2 µl/min) without seeing any effect on the 
glucose concentration (unpublished results). This could be due to higher adsorption of 
insulin to the tubing when the flow rate is lowered (Hewson, 2000). This is the reason 
why the insulin catheters in study III and V are perfused with a higher flow rate (1.33 
µl/min). The adsorption of insulin was measured in study III where the actual insulin 
concentration in the syringe (connected to the inflow tubing of the microdialysis 
catheter) was 14 mU/ml. The insulin concentration in the dialysate was then found to 
be 3.2 mU/ml. 
We did not measure the recovery in these studies, but a previous study, measuring 
interstitial insulin concentration in human skeletal muscle reported a recovery of 3 %, 
using the same catheters and similar (1 µl/min) perfusion flow rate (Sjöstrand, 1999). 
Taking this value and the observed adsorption of insulin (to the syringe, plastic tubing 
and dialysis membrane) into account the tissue immediately surrounding the catheter 
was estimated to be influenced by an insulin concentration of around 90 µU/ml in both 
study III and V. The study by MacLean et al perfusing with insulin showed a 
significant glucose uptake (measured as the difference between recovery of D-glucose 
and L-glucose) at 1.0 µU/ml with no further increase at 10 µU/ml. However, these 
authors did not report any adsorption of insulin (MacLean, 2001). 90 µU/ml insulin 
concentrations in serum are often seen during studies with the euglycemic 
hyperinsulinemic clamp technique (Rosdahl, 1998).  
One could argue that insulin causes an increased blood flow, although this is still under 
debate (Clark, 2003). If the blood flow was increased due to the insulin infusion the 
glucose concentration would rise, therefore resulting in an underestimation of the 
cellular effect of insulin. However, the present results (Study V) using the microdialysis 
ethanol technique indicates that insulin does not cause a change in nutritive blood flow 
when added to the perfusate.  
 
 Vanadate 
In study IV and V sodium metavanadate was infused through the microdialysis catheter 
in human skeletal muscle. The results clearly show that metavanadate mimics the effect 
of insulin. This is true also in insulin-resistant skeletal muscle where the effect does not 
seem to be decreased relative to healthy insulin-sensitive muscle. In fact, using 100 
mM sodium metavanadate, the effect on the interstitial glucose concentration was 
higher in the insulin-resistant subjects (Study V: -66 % in the exercised leg and -71 % 
in the rested leg) than in the healthy subjects (Study IV, no exercise had been 
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performed: 47%). The corresponding values for the interstitial lactate concentration 
were 61 % and 43 % (exercised and rested leg, respectively) in insulin-resistant muscle 
and 89 % in healthy muscle. A possible explanation for this different results could be 
systemic effect following the exercise on the glucose homeostasis (Ahlborg, 1975) 
That vanadate induces glucose lowering in insulin-resistant states is in agreement with 
other studies (Goldfine, 1995; McNeill, 1994; Shechter, 1990).  
After oral treatment in type-2 diabetic patients, 50% of the patients (4 out of 8) 
improved their insulin sensitivity (Willsky, 2001). In another study with oral treatment 
in healthy human subjects no effect of vanadyl sulphate on insulin sensitivity, fasting 
plasma glucose and insulin levels was found (Jentjens, 2002).  
The precise mechanism of action of vanadate on tissue glucose uptake has been 
difficult to reveal (reviewed in (Cam, 2000). The reasons for this could be that there are 
different kinds of vanadium salts used and also that the effect of different 
concentrations of the compound have been reported in different studies. The reason for 
choosing the metavanadate in the present studies was that a solution of metavanadate 
has a neutral pH (Elvingson, 1997).  
Earlier studies have shown a maximal rate of glucose transport at 30 mM vanadate in 
muscle samples (in vitro) from morbidly obese patients (Carey, 1995). The results from 
Study IV are in general agreement with this finding, since we observed a larger effect 
with 50 than with 10 mM of sodium metavanadate, whereas the effect was not further 
increased when100 mM sodium metavanadate was used. The concentrations of 
vanadate used in the present studies are however markedly higher than what is 
generally observed in the blood after oral treatment (Willsky, 2001). Therefore it is 
possible that the observed therapeutic effect of vanadate in insulin-resistant states is 
related to other effects than an increased glucose uptake in skeletal muscle. 
 
 
 GLUCOSE TOLERANCE  
In study IV and V we performed oral glucose tolerance tests to identify individuals with 
an insulin-resistant state. Since obesity decreases glucose tolerance by progressively 
increasing the insulin resistance (Carlsson, 1998), we chose to test obese subjects. In 
the Stockholm Diabetes Prevention program 12.5 % of the population with a BMI 
above 28 kg/m2 and 6.9 % of the population with a family history of diabetes have 
impaired glucose tolerance (Carlsson, 1998). The insulin resistance also increases with 
increasing age; in the above mentioned program 4.4 % of the population between 35-45 
years of age and 6.2 % of the population between 46-56 years of age had impaired 
glucose tolerance (0.8 % and 2.4 % had type-2 diabetes, respectively). With this in 
mind we tested obese subjects in the older age group (51.5 ±2.1 yr), preferable with a 
family history of diabetes. Out of 23 subjects tested prior to study V, eight were shown 
to have impaired glucose tolerance (blood glucose concentration above 6.7 mM but 
below 10 mM two hours after glucose ingestion) or a HOMA well above 2.77 (Nakai, 
2002).  
 
 
 PHYSICAL ACTIVITY AND INSULIN SENSITIVITY 
 In study V, the obese insulin-resistant subjects exercised with one leg for two hours in 
order to increase the insulin-sensitivity of one leg, the other leg serving as control. The 
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insulin-sensitivity should be increased after two hours since other investigators have 
reported enhanced insulin sensitivity in the working leg of healthy individuals after one 
hour of one-legged exercise at varying intensity (measuring glycogen synthase activity 
in muscle biopsies before and after a hyperinsulinemic-euglycemic clamp) 
(Wojtaszewski, 2000) as well as increased insulin sensitivity following 30 min of high 
intensity exercise (hyperinsulinemic-euglycemic clamps and measuring glycogen 
synthase activity in muscle biopsies) (Devlin, 1985). However, 30 min of one-legged 
exercise at moderate intensity did not increase insulin sensitivity in healthy or type-2 
diabetic subjects (measuring glycogen synthase activity in muscle biopsies before and 
after hyperinsulinemic-euglycemic clamps) (Dela, 1995).  
The increase in insulin sensitivity (measured with biopsies and hyperinsulinemic-
euglycemic clamps) after one bout of exercise may last for as long as 48 hours 
(Mikines, 1988). A previous microdialysis study shows that a 2 h exercise bout leads to 
a prolonged decrease in muscle interstitial glucose concentration. This decrease may 
last for 6-7 hours or more (Henriksson and Knol to be published in Acta Physiologica 
Scandinavica). To avoid these acute effects of exercise the microdialysis measurements 
were performed six hours after the exercise bout in Study V.  
The glucose concentration at basal, from the low-flow catheters was decreased in the 
working leg compared to the resting leg indicating an acute effect of exercise still 
present. This result is not seen in the high flow catheters, though. We have previously 
seen that the methodological variability for glucose and urea was lower when the 
perfusion flow rate was decreased (Study I). This higher methodological variability 
could be the reason why the lower glucose concentration is not detected in the high-
flow catheters. 
Part of the lowering of the glucose concentration in the working leg could however also 
represent the higher insulin sensitivity since the present results showed that the lowered 
effect of insulin on the interstitial glucose concentration in insulin-resistant muscle was 
normalized following the 2-hour bout of exercise. A previous study has indicated that 
the arterial-interstitial (a-i) difference in glucose concentration can be used as a 
measure of insulin sensitivity (Holmäng, 1998), as no arterial-interstitial (a-i) 
differences were found in insulin-resistant skeletal muscle but were present in insulin 
sensitive human skeletal muscle. Taken together, the available data indicate that the 
microdialysis technique could be used to measure the degree of insulin resistance in 
human skeletal muscle both from insulin infusion experiments and from measurements 
of the arterial-interstitial (a-i) glucose difference. 
 
 24 
 CONCLUSIONS 
 
The microdialysis technique has been shown to be useful in many ways since it was 
first introduced in human skeletal muscle. In this thesis the main focus has been to 
evaluate the technique of using very low perfusion flows in order to obtain equilibrium 
between interstitial and perfusion fluids and to use this technique to study glucose 
metabolism and insulin resistance in human skeletal muscle. 
 
We found that to obtain complete equilibration between the interstitial and perfusion 
fluids in human skeletal muscle, a perfusion flow rate as low as 0.16 µl/min is 
necessary with the presently used catheters (Study I).  
 
At these low perfusion flow rates a colloid needs to be included in the perfusion fluid in 
order to keep the fluid balance and in this thesis it was shown that the colloid dextran-
70 does not affect the metabolite concentrations in the collected dialysates (Study II). 
 
A high cut-off microdialysis membrane can be used to infuse insulin into human 
skeletal muscle and record its effect on metabolite concentrations (Study III). 
 
When the insulin-mimetic agent vanadate was infused via the microdialysis catheter 
into human skeletal muscle (Study IV), it was found to decrease the interstitial glucose 
concentration in a similar way as insulin, but in contrast to insulin (see below), the 
effect of vanadate was not diminished in insulin-resistant skeletal muscle and was not 
affected by exercise. 
 
Following one-leg cycling for two hours, the effect of insulin in insulin-resistant 
subjects tended to be higher in the working compared to the resting leg. The effect in 
the working leg was similar to the effect in healthy resting muscle seen in study III. 
Therefore it is concluded that a single bout of exercise normalizes the insulin effect on 
the interstitial glucose concentration in insulin-resistant human skeletal muscle. This is 
contrary to the effect seen after vanadate infusion, see above.  
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 POPULÄRVETENSKAPLIG SAMMANFATTNING  
 NY TEKNIK FÖR ATT STUDERA INSULINRESISTENS I 
SKELETTMUSKULATUR.  
Insulinresistens (sänkt insulinkänslighet) är ett känt riskfaktorsyndrom för 
hjärtkärlsjukdom, även kallat det metabola syndromet. Skelettmuskulaturen är den 
vävnad som till största delen svarar för insulinresistensen. Insulinresistensen kan vid 
ärftlig predisposition leda till typ-2 diabetes (”åldersdiabetes”).  
 
Känsligheten för insulin ökar med ökad fysisk aktivitet. Det betyder att man får en ökad 
insulinkänslighet i de muskler som har varit aktiva, men inte i de muskler som varit 
inaktiva. Ökningen i insulinkänslighet är troligen en av förklaringarna till varför fysisk 
träning är en av de bästa metoderna för att minska risken för att dö en alltför tidig död i 
hjärt-kärlsjukdom. Tillgängliga data antyder dessutom att en betydande effekt kan 
uppnås med en ganska beskedlig dos fysisk aktivitet. Mekanismerna bakom de positiva 
effekterna av en ökad fysisk aktivitet är idag inte helt kända. 
 
Det finns ett antal olika metoder för att mäta graden av insulinresistens hos en individ. 
Gemensamt för dessa är att de framförallt mäter insulinresistens i hela kroppen. Många 
gånger skulle det räcka med att enbart titta på skelettmuskulaturen eftersom 
insulinresistensen ofta syns först där.  
 
Mikrodialys är en metod som gör det möjligt att kontinuerligt följa en vävnads 
ämnesomsättning. En mikrodialyskateter är en tunn slang tjock som en fin 
injektionsnål. Den kan liknas vid ett konstgjort blodkärl (kapillär), som förs in i den 
vävnad man vill studera (i vårt fall human skelettmuskulatur). Katetern består bl a av ett 
semipermeabelt membran och en fysiologisk buffertlösning spolas långsamt igenom 
katetern. Kemiska substanser diffunderar till och från mikrodialyskatetern på samma 
sätt som ämnen diffunderar till och från en kapillär. Vätskan som har spolats igenom 
katetern innehåller olika substanser, t ex glukos, i samma koncentration som i muskelns 
vävnadsvätska. Mikrodialysen ger därmed ett mer vävnadsspecifikt värde än ett 
blodprov som representerar ett medelvärde av alla kroppens organ.  
 
Först utvecklade vi mikrodialystekniken för att kunna använda den på ett enkelt sätt i 
skelettmuskulaturen. Genom att genomföra en undersökning där vi successivt sänkte 
flödeshastigheten för vätskan som spolades genom mikrodialyskatetern kom vi fram till 
vilken flödeshastighet som måste användas för att se sanna koncentrationer av olika 
ämnen i vävnadsvätskan. Om man vid mikrodialys använder en hög flödeshastighet så 
hinner inte diffusionen med att skapa en jämvikt mellan vävnadsvätskan och 
mikrodialyskatetern – det blir en lägre koncentration av olika ämnen i 
mikrodialyskatetern än i vävnadsvätskan. I undersökningar där man använder en hög 
flödeshastighet måste man genomföra kalibrering av mikrodialyskatetern för att få fram 
den sanna koncentrationen av ett ämne i vävnadsvätskan. 
Vi insåg att vid de låga flödeshastigheter som vi ville använda så försvann en del av 
perfusionsvätskan (den vätska som spolas igenom mikrodialyskatetern) ut i vävnaden. 
För att motverka detta tillsattes en kolloid i vätskan, dvs. en molekyl som är för stor för 
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att kunna diffundera ut i vävnaden och som därför håller kvar vätskan i 
mikrodialyskatetern (bildar sk kolloidosmotiskt tryck). I arbete II genomförde vi en 
undersökning där vi visade att denna kolloid (dextran-70) inte påverkade resultaten av 
mikrodialysen i övrigt. 
 
Mikrodialystekniken användes sedan för att se om det var möjligt att studera effekter av 
hormonet insulin i skelettmuskulatur genom att tillsätta det i perfusionsvätskan. Insulin 
är det hormon i kroppen som får musklerna att ta upp glukos (socker) från blodet och 
därmed sänka blodsockernivån. När insulin tillsattes i perfusionsvätskan kunde vi se att 
insulinet diffunderade ut till muskeln eftersom skelettmuskulaturen svarade genom att 
ta upp mer socker (glukoskoncentrationen i mikrodialyskatetern sänktes). 
Vi fortsatte därefter med att tillsätta vanadat i perfusionsvätskan. Vanadat är ett ämne 
som har liknande effekter som insulin. I mindre undersökningar i USA har vanadat 
testats som ett möjligt läkemedel till patienter med typ-2 diabetes. Man har då sett att 
vanadat sänker blodsockernivån i blodet.  
När vanadat fanns med perfusionsvätskan sänktes glukoskoncentrationen i 
mikrodialyskatetern – samma resultat som när vi tillsatte insulin. I denna undersökning 
inkluderade vi även några äldre insulinresistenta individer som också visade på samma 
resultat. Kanske går vanadat ”förbi” deras insulinresistens.  
 
I den sista undersökningen tillsatte vi antingen insulin eller vanadat i 
mikrodialyskatetrarna (insulin i två och vanadat i två). Försökspersonerna var alla 
insulinresistenta men fick före undersökningen cykla med ena benet på en 
motionscykel i två timmar. 
 
Efter en-bens cyklingen hade försökspersonerna ett ben där musklerna var 
insulinresistenta (vilobenet) och ett ben som var insulinkänsligt (arbetsbenet). 
Mikrodialysundersökningen visade att insulin hade bättre effekt på 
glukoskoncentrationen i arbetsbenet än i vilobenet, medan vanadat hade lika bra effekt i 
båda benen. Effekten av insulin i arbetsbenet var lika stor som insulineffekten hos de 
friska individer studerades i arbete III. Slutsatsen är att endast ett arbetspass kan 
normalisera skelettmuskelns insulinkänslighet. 
Arbetet stöder också teorin att effekten av vanadat inte påverkades av 
insulinresistensen. Vanadateffekten var varken sänkt hos dessa insulinresistenta 
individer i jämförelse med de friska individerna i arbete IV eller förändrades av arbete. 
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